References
- Wassermann AM, Wawer M, Bajorath J. Activity landscape representations for structure-activity relationship analysis. J. Med. Chem. 53(23), 8209–8223 (2010).
- Stumpfe D, Hu Y, Dimova D, Bajorath J. Recent progress in understanding activity cliffs and their utility in medicinal chemistry. J. Med. Chem. 57(1), 18–28 (2014).
- Stumpfe D, Bajorath J. Monitoring global growth of activity cliff information over time and assessing activity cliff frequencies and distributions. Future Med. Chem. 7(12), 1565–1579 (2015).
- Hu X, Hu Y, Vogt M, Stumpfe D, Bajorath J. MMP-cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs. J. Chem. Inf. Model. 52(5), 1138–1145 (2012).
- Griffen E, Leach AG, Robb GR, Warner DJ. Matched molecular pairs as a medicinal chemistry tool. J. Med. Chem. 54(22), 7739–7750 (2014).
- Hussain J, Rea C. Computationally efficient algorithm to identify matched molecular pairs (MMPs) in large data sets. J. Chem. Inf. Model. 50(3), 339–348 (2010).
- Shoichet BK. Screening in a spirit haunted world. Drug Discovery Today 11(13–14), 607–615 (2006).
- Baell J, Walters MA. Chemical con artists foil drug discovery. Nature 513(7519), 481–483 (2014).
- Hu Y, Bajorath J. Compound promiscuity: what can we learn from current data? Drug Discov. Today 18(13), 644–650 (2013).
- Bredel M, Jacoby E. Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat. Rev. Genet. 5(4), 262–275 (2004).
- Paolini GV, Shapland RH, van Hoorn WP, Mason JS, Hopkins AL. Global mapping of pharmacological space. Nat. Biotechnol. 24(7), 805–815 (2006).
- Boran AD, Iyengar R. Systems approaches to polypharmacology and drug discovery. Curr. Opin. Drug Discov. Devel. 13(3), 297–309 (2010).
- Gaulton A, Hersey A, Nowotka M et al. The ChEMBL database in 2017. Nucleic Acids Res. 45(D1), D945–D954 (2017).
- Wang Y, Suzek T, Zhang J et al. PubChem BioAssay: 2014 update. Nucleic Acids Res. 42(D1), D1075–D1082 (2014).
- Hu Y, Bajorath J. Entering the ‘big data’ era in medicinal chemistry: molecular promiscuity analysis revisited. Future Sci. OA 3(2), FSO179 (2017).
- Hu Y, Bajorath J. Promiscuity profiles of bioactive compounds: potency range and difference distributions and the relation to target numbers and families. Med. Chem. Commun. 4(8), 1196–1201 (2013).
- Dimova D, Hu Y, Bajorath J. Matched molecular pair analysis of small molecule microarray data identified promiscuity cliffs and identifies molecular origins of extreme compound promiscuity. J. Med. Chem. 55(22), 10220–10228 (2012).
- Dimova D, Gilberg E, Bajorath J. Identification and analysis of promiscuity cliffs formed by bioactive compounds and experimental implications. RSC Adv. 7, 58–66 (2017).
- Hu Y, Jasial S, Gilberg E, Bajorath J. Structure-promiscuity relationship puzzles – extensively assayed analogs with large differences in target annotations. AAPS J. 19(3), 856–864 (2017).